Improved Mortality But Increased Economic Burden of Disease in Compensated and Decompensated Cirrhosis
暂无分享,去创建一个
[1] Jennifer E. Moore,et al. Agency for Healthcare Research and Quality , 2020, Definitions.
[2] Tetsuya Nakamura,et al. High-fat diet-derived free fatty acids impair the intestinal immune system and increase sensitivity to intestinal epithelial damage. , 2019, Biochemical and biophysical research communications.
[3] Z. Henry. Readmissions for Cirrhosis Within the Healthcare Readmissions Reduction Program: A Hidden Challenge. , 2019, The American journal of gastroenterology.
[4] M. Boustani,et al. Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database , 2019, Clinical and translational gastroenterology.
[5] S. Cohen-Mekelburg,et al. Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program. , 2019, The American journal of gastroenterology.
[6] G. Giustino,et al. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease , 2018, Gut and liver.
[7] J. Kobiela,et al. Statins and Colorectal Cancer - A Systematic Review. , 2018, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[8] S. Black,et al. Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic Patients: A Model Based on the Administrative Database , 2019, Hepatology.
[9] R. Shah,et al. Incidence and predictors of 30-day readmissions in patients hospitalized with chronic pancreatitis: A nationwide analysis. , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[10] M. Simard,et al. Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10 , 2018, Medical care.
[11] S. Asch,et al. Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013 , 2017, The American Journal of Gastroenterology.
[12] Howard R. Underwood,et al. Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database , 2017, Journal of clinical gastroenterology.
[13] P. Kamath,et al. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States , 2016, Hepatology.
[14] E. Tapper,et al. Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[15] M. Mittleman,et al. A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] F. Kanwal. Decreasing mortality in patients hospitalized with cirrhosis. , 2015, Gastroenterology.
[17] A. Barritt,et al. Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. , 2015, Gastroenterology.
[18] Baljendra Kapoor,et al. Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-Up , 2014, Seminars in Interventional Radiology.
[19] P. Kamath,et al. Prevalence and in‐hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States , 2014, Alimentary pharmacology & therapeutics.
[20] Ruben Amarasingham,et al. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[21] Z. Younossi,et al. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[22] Terry M. Therneau,et al. Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.
[23] R. Woodman,et al. Efficacy of a chronic disease management model for patients with chronic liver failure. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] M. Clèries,et al. Hospital mortality over time in patients with specific complications of cirrhosis , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[25] M. Stepanova,et al. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[26] Michael L Volk,et al. Hospital Readmissions Among Patients With Decompensated Cirrhosis , 2012, The American Journal of Gastroenterology.
[27] E. Schiff,et al. The current economic burden of cirrhosis. , 2011, Gastroenterology & hepatology.
[28] James Nguyen,et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] B. Runyon. Management of adult patients with ascites due to cirrhosis: An update , 2009, Hepatology.
[30] G. D’Amico,et al. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.
[31] R. de Franchis. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. , 2005, Journal of hepatology.
[32] W. Kim,et al. Burden of liver disease in the United States: Summary of a workshop , 2002, Hepatology.